Health Affairs, 26, no. 1 (2007): 97-110 doi: 10.1377/hlthaff.26.1.97 © 2007 by Project HOPE	New Online   Pay Cuts For Medicare Docs   Access To Care Woes   Public Coverage More Efficient   Empowering Consumers

This Article Figures Only Full Text (HTML) Reprint (PDF) Technical Appendix Submit a response to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (6) Citing Articles via Google Scholar Google Scholar Articles by Cutler, D. M. Articles by Cremieux, P. Search for Related Content PubMed PubMed Citation Articles by Cutler, D. M. Articles by Cremieux, P. Related Collections Cardiovascular Disease Chronic Care Consumer Issues Pharmaceuticals Research And Technology Health Spending Related Blog Posts

Value & Price

The Value Of Antihypertensive Drugs: A Perspective On Medical Innovation

Using national survey data and risk equations from the Framingham Heart Study, we quantify the impact of antihypertensive therapy changes on blood pressures and the number and cost of heart attacks, strokes, and deaths. Antihypertensive therapy has had a major impact on health. Without it, 1999–2000 average blood pressures (at age 40+) would have been 10–13 percent higher, and 86,000 excess premature deaths from cardiovascular disease would have occurred in 2001. Treatment has generated a benefit-to-cost ratio of at least 6:1, but much more can be achieved. More effective use of antihypertensive medication would have an impact on mortality akin to eliminating all deaths from medical errors or accidents.

                      What's this?

Related Blog Posts:

This article has been cited by other articles:

				J. M. McWilliams, E. Meara, A. M. Zaslavsky, and J. Z. Ayanian Health of Previously Uninsured Adults After Acquiring Medicare Coverage JAMA, December 26, 2007; 298(24): 2886 - 2894. [Abstract] [Full Text] [PDF]

				K. E. Thorpe, D. H. Howard, and K. Galactionova Differences In Disease Prevalence As A Source Of The U.S.-European Health Care Spending Gap Health Aff., November 1, 2007; 26(6): w678 - w686. [Abstract] [Full Text] [PDF]

				G. Long, D. M. Cutler, and E. R. Berndt Antihypertensive drugs: a perspective on the value of improved blood pressure control in the USA Eur. Heart J. Suppl., May 1, 2007; 9(suppl_B): B19 - B22. [Abstract] [Full Text] [PDF]

				T. A. Brennan and M. M. Mello Sunshine Laws and the Pharmaceutical Industry JAMA, March 21, 2007; 297(11): 1255 - 1257. [Full Text] [PDF]

				S. Harper, J. Lynch, S. Burris, and G. Davey Smith Trends in the Black-White Life Expectancy Gap in the United States, 1983-2003 JAMA, March 21, 2007; 297(11): 1224 - 1232. [Abstract] [Full Text] [PDF]

				A. B. Rosen, D. M. Cutler, D. M. Norton, H. M. Hu, and S. Vijan The Value Of Coronary Heart Disease Care For The Elderly: 1987-2002 Health Aff., January 1, 2007; 26(1): 111 - 123. [Abstract] [Full Text] [PDF]